100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in both
Our Recommendation
Ramigo 5mg Tablet 10s
3,320+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Hypertension (high blood pressure)
Customers also bought
More About Rami Race 5mg Tablet 10s
Benefits
In Hypertension (high blood pressure) Rami Race 5 Tablet relaxes the blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Rami Race 5 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Rami Race 5 Tablet is a combination of two medicines: Amlodipine and ramipril which lower blood pressure effectively. It works by relaxing blood vessels so that blood flows more smoothly and the heart can pump blood more efficiently.
Unsafe: Avoid consuming alcohol with Rami Race 5 Tablet 10 Tablet Knoll Pharma Ltd as it is deemed unsafe.
Seek medical advice from your doctor: Rami Race 5 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Safe when prescribed by an expert: Rami Race 5 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Rami Race 5 Tablet may cause side effects which could affect your ability to drive. Rami Race 5 Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Caution Advised: Rami Race 5 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Rami Race 5 Tablet may be needed. Doctor consultation is advised. Regular monitoring of blood pressure is recommended for dose adjustment.
Caution Advised: Rami Race 5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Rami Race 5 Tablet may be needed. Doctor consultation is advised. Inform your doctor if you develop any signs and symptoms of jaundice while taking this medicine.
What if I forget to take it?
If a dose of Rami Race 5 Tablet 10 Tablet Knoll Pharma Ltd is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
M-17, Pharma Tower, Basement & Ground Floor, Badli Industrial Area, New Delhi 110 042
References
Hilal-Dandan R. Renin and Angiotensin. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 733
Pfeffer MA, Opie LH. Inhibitors of the Renin-Angiotensin-Aldosterone System. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 143-44
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1195-96
Ramipril. New York, New York: Pfizer, Inc.; 1991 (19 Mar. 2019)
Ramipril. South Ruislip, UK: Aurobindo Pharma - Milpharm Ltd.; 2011 (19 Jun. 2019)
National Health Service. Ramipril; 2018 (19 Jun. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
CiplaMed. Ramipril (25 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Health Articles
